New antimalarial more effective than current treatment, but no improvement in adverse birth outcomes

by

A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.

Leave A Comment

Your email address will not be published. Required fields are marked *